Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%

Healthcare

Page 50
  1. Mar 10, 2026 · 16:05 · NVRS

    Noveris Announces Resignation Of CEO

    Noveris Announces Resignation Of CEO

    01
  2. Mar 10, 2026 · 14:55 · KETA

    Tripsitter investor Canal Front acquires 160,000 shares

    Tripsitter investor Canal Front acquires 160,000 shares

    02
  3. Mar 10, 2026 · 08:00 · AIDR

    Rocket Doctor Strengthens New York Footprint with Additional In-Network Medicare Advantage Agreement

    Rocket Doctor Strengthens New York Footprint with Additional In-Network Medicare Advantage Agreement

    03
  4. Mar 10, 2026 · 08:00 · BIOV

    BioVaxys and AI-Guided mRNA Immunotherapy Leader Adiverna Enter Collaboration to Develop Companion Animals Vaccines

    BioVaxys and AI-Guided mRNA Immunotherapy Leader Adiverna Enter Collaboration to Develop Companion Animals Vaccines

    04
  5. Mar 10, 2026 · 07:25 · KNE

    Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership

    Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership

    05
  6. Mar 10, 2026 · 07:04 · SPLY

    Safe Supply Streaming Co Ltd. Achieves U.S. Federal Vendor Registration and Secures Municipal Vendor Approval in Boca Raton, Florida

    Safe Supply Streaming Co Ltd. Achieves U.S. Federal Vendor Registration and Secures Municipal Vendor Approval in Boca Raton, Florida

    06
  7. Mar 10, 2026 · 07:01 · TLT

    Theralase(R) Closes $1.1 M Non-Brokered Private Placement

    Theralase(R) Closes $1.1 M Non-Brokered Private Placement

    07
  8. Mar 10, 2026 · 07:00 · MSCL

    Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference

    Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference

    08
  9. Mar 10, 2026 · 07:00 · MBX

    Microbix's Clot-Buster Drug Project Advances

    Microbix's Clot-Buster Drug Project Advances

    09
  10. Mar 09, 2026 · 20:12 · VHI

    Vitalhub's Novari Health rolls out tech in Niagara

    Vitalhub's Novari Health rolls out tech in Niagara

    10
  11. Mar 09, 2026 · 18:52 · TLT

    Theralase's Rutherrin data point to effectiveness

    Theralase's Rutherrin data point to effectiveness

    11
  12. Mar 09, 2026 · 18:32 · TELO

    Telo Genomics closes debenture financing

    Telo Genomics closes debenture financing

    12
  13. Mar 09, 2026 · 14:53 · DTC

    Defence Therapeutics closes $9.59M private placement

    Defence Therapeutics closes $9.59M private placement

    13
  14. Mar 09, 2026 · 08:30 · PRN

    Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24

    Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24

    14
← Newer Older →